Display options
Share it on

HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(2):119-27.

Perioperative evaluation of primary hemostasis in patients undergoing mitral valve repair.

HSR proceedings in intensive care & cardiovascular anesthesia

F Pappalardo, P Della Valle, G Maj, A Franco, A Lattuada, G Landoni, A Zangrillo, A D'Angelo

Affiliations

  1. Department of Anesthesia and Intensive Care, Università Vita-Salute San Raffaele, Milan, Italy.

PMID: 23440905 PMCID: PMC3484616

Abstract

INTRODUCTION: No data exist on the prevalence of primary hemostatic defects and acquired von Willebrand disease in mitral valve prolapse with severe regurgitation.

METHODS: Primary hemostasis was evaluated by PFA-100, von Willebrand Factor Antigen (vWF:Ag) and Ristocetin cofactor (vWF:RiCof) assays in a prospective observational trial. Sixty-five consecutive patients with mitral regurgitation (study group) or aortic stenosis (control group) who were operated for mitral valve repair or aortic valve replacement were enrolled in the study.

RESULTS: There were no differences in Closure Time in the two groups at all time points. The concentration of plasma vWF: Ag was within normal limits in all patients preoperatively; after surgery, a significant increase was observed in both groups from baseline (199 +/- 144 mcg/dL vs. 295 +/-141 mcg/dL in the study group, p=0.002; 243 +/- 141 mcg/dLl vs 338 +/- 154 mcg/dL in the control group, p=0.009). The ratio of vWF:RiCof to vWF:Ag was slightly decreased preoperatively in both groups (ratio= 0.91) and showed a marked increase in the postoperative period (ratio=0.22) as, probably, new hemostatically effective large multimeric forms of vWF were released.

CONCLUSIONS: Patients who present for surgery with a valvular pathology with high shear stress have some degree of primary hemostasis defect; nevertheless, the potent stimulus of surgery and the correction of the underlying disease allow quick restoration of vWF activity and normalization of PFA-100.

Keywords: aortic surgery; cardiac surgery; mitral surgery; platelect function; von Willebrand

References

  1. Lancet. 1996 Mar 9;347(9002):689-90 - PubMed
  2. Blood. 2003 Feb 1;101(3):946-8 - PubMed
  3. Semin Thromb Hemost. 1998;24(2):195-202 - PubMed
  4. Blood Coagul Fibrinolysis. 2001 Mar;12(2):85-93 - PubMed
  5. N Engl J Med. 2003 Jul 24;349(4):323-5 - PubMed
  6. Blood. 2002 Nov 15;100(10):3604-10 - PubMed
  7. J Thorac Cardiovasc Surg. 2001 Jul;122(1):190-1 - PubMed
  8. N Engl J Med. 2004 Aug 12;351(7):683-94 - PubMed
  9. Ann Thorac Surg. 2006 Mar;81(3):1114-6 - PubMed
  10. Haemophilia. 2003 May;9(3):298-302 - PubMed
  11. Thromb Haemost. 1988 Oct 31;60(2):230-1 - PubMed
  12. Lancet. 1992 Jul 4;340(8810):35-7 - PubMed
  13. J Thromb Thrombolysis. 2003 Jun;15(3):141-9 - PubMed
  14. Thromb Res. 1996 Aug 15;83(4):299-306 - PubMed
  15. Blood Coagul Fibrinolysis. 2004 Sep;15(6):505-11 - PubMed
  16. Circulation. 2000 Sep 12;102(11):1290-5 - PubMed
  17. Semin Thromb Hemost. 1995;21 Suppl 2:106-12 - PubMed
  18. N Engl J Med. 2003 Jul 24;349(4):343-9 - PubMed
  19. Blood Coagul Fibrinolysis. 2002 Jun;13(4):349-53 - PubMed
  20. Am J Cardiol. 2001 Jan 1;87(1):107-10, A9 - PubMed
  21. Blood. 1986 Mar;67(3):758-61 - PubMed
  22. Thromb Haemost. 1999 Jul;82(1):35-9 - PubMed
  23. Heart. 2002 Jul;88(1):87-8 - PubMed
  24. Ann Thorac Surg. 1987 Nov;44(5):514-6 - PubMed

Publication Types